Position in AMGN
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$6,291,835
-$304,296 QoQ
Shares Held
17,375
-7.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#728
of 3,140 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Derivatives in AMGN
reported options exposure · as of Dec 31, 2024CallValue
$286,704
CallShares
1,100
PutValue
$286,704
PutShares
1,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Valeo Financial Advisors, LLC holds $209,939,553 across 14 Drug Manufacturers - General names. AMGN ranks #5 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
130,247 | $156,222,172 | |
| 2 | JNJ |
Johnson & Johnson
|
62,574 | $15,891,918 | |
| 3 | ABBV |
AbbVie Inc.
|
47,980 | $12,073,687 | |
| 4 | MRK |
Merck & Co., Inc.
|
54,116 | $6,953,906 | |
| 5 | AMGN |
Amgen Inc
This page
|
17,375 | $6,291,835 | |
| 6 | PFE |
Pfizer Inc
|
169,378 | $4,078,622 | |
| 7 | AZN |
Astrazeneca PLC
|
9,817 | $1,861,499 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
29,784 | $1,716,154 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,291,835 | 17,375 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $6,596,131 | 18,747 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $6,883,983 | 21,032 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $6,352,322 | 22,510 | Shares | Sole | 2025-11-03 | |
| 2025-03-31 | $13,841,854 | 44,429 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $286,704 | 1,100 | Call | Sole | 2025-01-30 | |
| 2024-12-31 | $286,704 | 1,100 | Put | Sole | 2025-01-30 | |
| 2024-12-31 | $11,134,540 | 42,720 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $13,826,031 | 42,910 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $13,714,992 | 43,895 | Shares | Sole | 2024-07-10 | |
| 2023-12-31 | $13,426,340 | 46,616 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $12,387,417 | 46,091 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $10,085,258 | 45,425 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $10,297,583 | 42,596 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $10,534,490 | 40,110 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $8,734,024 | 38,749 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $9,193,333 | 37,786 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $9,285,646 | 38,399 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $8,319,840 | 36,982 | Shares | Sole | 2022-01-07 | |
| 2021-09-30 | $8,175,541 | 38,446 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $9,002,906 | 36,935 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $9,042,750 | 36,344 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $8,337,359 | 36,262 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $3,235,710 | 12,731 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $3,217,366 | 13,641 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $2,636,300 | 13,004 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||